Ximing Yang
Professor and Chief of Urological Pathology
Northwestern Medicine
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (1)
Patient selection for focal therapy (FT) of prostate cancer requires the assessment of MRI and biopsy results. However, there is currently little guidance for the utility of PSMA PET/CT in FT planning. We describe the case of a man originally considered an ideal candidate for FT based on biopsy and MRI who was found to have a contralateral lesion‐harboring cancer detected only on PSMA PET/CT. Trial Registration: ClinicalTrials.gov identifier: NCT05852041
Year:
2025
Collaborators (2)
Ashley Ross
Northwestern University Feinberg School of Medicine
UNITED STATES
Vikas Mehta
Attending Pathologist
Northwestern Medicine
UNITED STATES
Make your next move.
Prepare your application
Review drafts before you send them.